Susquehanna International Group’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.92M | Buy |
406,118
+269,376
| +197% | +$1.93M | ﹤0.01% | 1863 |
|
|
2025
Q1 | $819K | Sell |
136,742
-14,876
| -10% | -$89.1K | ﹤0.01% | 3651 |
|
|
2024
Q4 | $1.18M | Buy |
151,618
+108,248
| +250% | +$844K | ﹤0.01% | 2743 |
|
|
2024
Q3 | $468K | Sell |
43,370
-59,830
| -58% | -$646K | ﹤0.01% | 3739 |
|
|
2024
Q2 | $870K | Buy |
103,200
+10,267
| +11% | +$86.6K | ﹤0.01% | 2747 |
|
|
2024
Q1 | $625K | Buy |
92,933
+5,185
| +6% | +$34.8K | ﹤0.01% | 3237 |
|
|
2023
Q4 | $516K | Buy |
87,748
+55,520
| +172% | +$326K | ﹤0.01% | 3819 |
|
|
2023
Q3 | $314K | Buy |
32,228
+11,593
| +56% | +$113K | ﹤0.01% | 3983 |
|
|
2023
Q2 | $244K | Sell |
20,635
-95,175
| -82% | -$1.13M | ﹤0.01% | 4440 |
|
|
2023
Q1 | $1.25M | Buy |
115,810
+84,766
| +273% | +$915K | ﹤0.01% | 2577 |
|
|
2022
Q4 | $359K | Sell |
31,044
-44,458
| -59% | -$514K | ﹤0.01% | 3656 |
|
|
2022
Q3 | $1.13M | Buy |
75,502
+40,157
| +114% | +$599K | ﹤0.01% | 2373 |
|
|
2022
Q2 | $319K | Buy |
+35,345
| New | +$319K | ﹤0.01% | 3923 |
|
|
2021
Q2 | – | Sell |
-284,250
| Closed | -$2.5M | – | 5393 |
|
|
2021
Q1 | $2.5M | Buy |
+284,250
| New | +$2.5M | ﹤0.01% | 1864 |
|
|
2019
Q3 | – | Sell |
-5,926
| Closed | -$62K | – | 4511 |
|
|
2019
Q2 | $62K | Buy |
+5,926
| New | +$62K | ﹤0.01% | 4241 |
|
|
2018
Q4 | – | Sell |
-7,699
| Closed | -$317K | – | 3825 |
|
|
2018
Q3 | $317K | Buy |
+7,699
| New | +$317K | ﹤0.01% | 2381 |
|